Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

BZDs are often a difficult drug class to cease once neuroadaptation has occurred; recommendations usually involve gradual dose reductions of variable rates.

Original research | 2022
Withdrawal, Clinical guidance
Manuel | 2020
la réduction des méfaits, les services enveloppants, à propos des prescripteurs, les services sociaux, les drogues illégales, les stimulants, s'injecter les drogues
Video | 2022
Drug checking, Illegal drugs, Harm reduction
Guidelines | 2022
Clinical guidance, About prescribers, Injecting drugs

Underutilized regulations allow non-Opioid Treatment Program (OTP) providers to administer methadone for opioid withdrawal for up to 72 hours while arranging ongoing care.

Original research | 2022
Hospitals, Transitions in care/treatment, Substitution/OAT

As supervised consumption services (SCS) are scaled-up across Canada, information on those who require help injecting is necessary to inform equitable service uptake.

Original research | 2022
Equity, About PWUD, Illegal drugs, Sex/Gender , SCS/OPS

The objective was to employ latent class analysis (LCA) to empirically categorize and extract potential typologies of poly-substance users within a multi-site cohort of illicit opioid and other dru

Original research | 2009
About PWUD, Illegal drugs
Training | 2022
Harm reduction, About prescribers, Illegal drugs

Morphine preparations are known to have small amounts of codeine as an impurity estimated to be about 0.04%

Original research | 2009
Drug checking, Substitution/OAT
Case study | 2022
Safer supply, About prescribers, Policy/Regulatory, Wrap-around services, Barriers and enablers, Evidence base, Social services, Harm reduction
Commentary | 2022
Safer supply, About PWUD, Social benefits

Integrating the social-ecological framework, we focus on individual characteristics, personal and family members' experience with OUD, and spatial access to OUD at the community level.

Original research | 2022
Stigma

The purpose of this paper is to provide findings related to two research questions: first,do low-threshold employment programmes have the potential to contribute to positive recovery capital, and i

Original research | 2016
Peer/PWLLE program involvement

This paper asks, what values do people who use drugs hold surrounding drug use and drug policy, and what factors predict these values?

Original research | 2022
About PWUD, Policy/Regulatory

We estimated the impact of OAT on hospitalisations for non-viral infections and examine trends in incidence over time.

Original research | 2022
Substitution/OAT, Injecting drugs, About PWUD, Outcomes, Illegal drugs, Hospitals
Slide deck | 2022
Hospitals, Harm reduction, Policy/Regulatory, Stigma

This study examines whether hospital admission and discharge are associated with increased risk of opioid-related death.

Original research | 2021
Overdose, Mortality, About PWUD, Hospitals
Commentary | 2021
Harm reduction, Policy/Regulatory, Barriers and enablers, Peer/PWLLE program involvement, SCS/OPS, Hospitals

Affiner votre recherche

Mots clés
Format
Région